CD274 and renal cell carcinoma: It seems to be associated with worse prognosis in RCC (Lu et al. 2020); however, studies have not clearly identified a correlation between treatment efficacy and PD-L1 status (Motzer et al. 2022a, 2021c; Rini et al. 2019a).